flâneur

What’s in an Egg: The Age-Old Vaccine Production Method Lives On | Infection Control Today

infectioncontroltoday.com · 1,347 words · saved by 1 readers

For more than 80 years, the humble chicken egg has quietly powered one of modern medicine’s most vital defenses: vaccines. Even in an age of recombinant DNA, mRNA platforms, and cell-based innovations, more than 80% of the world’s influenza vaccines still begin in an egg. The process is time-tested, affordable, and reliable—but also imperfect. read this to learn more.

For more than 80 years, the humble chicken egg has quietly powered one of modern medicine’s most vital defenses: vaccines. Even in an age of recombinant DNA, mRNA platforms, and cell-based innovations, more than 80% of the world’s influenza vaccines still begin in an egg. The process is time-tested, affordable, and reliable—but also imperfect. read this to learn more. For over 8 decades, chicken eggs have been at the heart of vaccine production. While newer technologies for vaccine development exist, egg-based vaccines still account for over 80% of influenza (flu) vaccines produced…

saved by

related reading